Literature DB >> 15105152

Development of a liposome formulation of ethambutol.

Theresa Wiens1, Thomas Redelmeier, Yossef Av-Gay.   

Abstract

A liposomal formulation capable of encapsulating 76 to 92% of the antimycobacterial drug ethambutol and showing prolonged in vitro release kinetics is described. In vitro efficacy is equivalent to that of the free drug, suggesting that encapsulation of ethambutol has the potential to shorten the current regimens for tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15105152      PMCID: PMC400583          DOI: 10.1128/AAC.48.5.1887-1888.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

1.  Interactions of liposomes and lipid-based carrier systems with blood proteins: Relation to clearance behaviour in vivo.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1998-06-08       Impact factor: 15.470

2.  Prolonged release biodegradable vesicular carriers for rifampicin--formulation and kinetics of release.

Authors:  M P Kamath; B D Shenoy; S B Tiwari; R Karki; N Udupa; M Kotian
Journal:  Indian J Exp Biol       Date:  2000-02       Impact factor: 0.818

Review 3.  Drug properties affecting aerosol behavior.

Authors:  S Suarez; A J Hickey
Journal:  Respir Care       Date:  2000-06       Impact factor: 2.258

4.  Efficacies of liposome-encapsulated streptomycin and ciprofloxacin against Mycobacterium avium-M. intracellulare complex infections in human peripheral blood monocyte/macrophages.

Authors:  S Majumdar; D Flasher; D S Friend; P Nassos; D Yajko; W K Hadley; N Düzgüneş
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

5.  Intracellular killing of Mycobacterium avium complex by rifapentine and liposome-encapsulated amikacin.

Authors:  L E Bermudez; M Wu; L S Young
Journal:  J Infect Dis       Date:  1987-09       Impact factor: 5.226

6.  Uptake of adriamycin into large unilamellar vesicles in response to a pH gradient.

Authors:  L D Mayer; M B Bally; P R Cullis
Journal:  Biochim Biophys Acta       Date:  1986-05-09

Review 7.  Use of liposome preparation to treat mycobacterial infections.

Authors:  L E Bermudez
Journal:  Immunobiology       Date:  1994-10       Impact factor: 3.144

8.  Pharmacokinetic comparison of intravenous carbendazim and remote loaded carbendazim liposomes in nude mice.

Authors:  Lee Jia; Mark Garza; Hong Wong; Dody Reimer; Thomas Redelmeier; Jim B Camden; Steve D Weitman
Journal:  J Pharm Biomed Anal       Date:  2002-04-01       Impact factor: 3.935

9.  Pharmacokinetics of ethambutol under fasting conditions, with food, and with antacids.

Authors:  C A Peloquin; A E Bulpitt; G S Jaresko; R W Jelliffe; J M Childs; D E Nix
Journal:  Antimicrob Agents Chemother       Date:  1999-03       Impact factor: 5.191

10.  Interactions of liposomes with serum proteins.

Authors:  F Bonté; R L Juliano
Journal:  Chem Phys Lipids       Date:  1986 Jun-Jul       Impact factor: 3.329

View more
  4 in total

1.  Quantitative structure-property relationship modeling of remote liposome loading of drugs.

Authors:  Ahuva Cern; Alexander Golbraikh; Aleck Sedykh; Alexander Tropsha; Yechezkel Barenholz; Amiram Goldblum
Journal:  J Control Release       Date:  2011-12-01       Impact factor: 9.776

Review 2.  Membrane Organization Strategies in Vesicular Antibiotic Delivery.

Authors:  Paul R Meers
Journal:  J Membr Biol       Date:  2022-01-11       Impact factor: 2.426

Review 3.  Carbohydrate-Based Host-Guest Complexation of Hydrophobic Antibiotics for the Enhancement of Antibacterial Activity.

Authors:  Daham Jeong; Sang-Woo Joo; Vijay Vilas Shinde; Eunae Cho; Seunho Jung
Journal:  Molecules       Date:  2017-08-08       Impact factor: 4.411

Review 4.  Nanocarrier-Based Approaches for the Efficient Delivery of Anti-Tubercular Drugs and Vaccines for Management of Tuberculosis.

Authors:  Amarjitsing Rajput; Satish Mandlik; Varsha Pokharkar
Journal:  Front Pharmacol       Date:  2021-12-21       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.